Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Teriflunomide”

61 trials

Showing 20 of 61 results

Testing effectiveness (Phase 2)Study completedNCT00811395
What this trial is testing

Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Sanofi 182
Testing effectiveness (Phase 2)Study completedNCT04056897
What this trial is testing

Comparative Study of the Efficacy and Safety of BCD-132 With Teriflunomide and Placebo in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Biocad 271
Large-scale testing (Phase 3)Study completedNCT05385744
What this trial is testing

An International, Multicenter, Randomized, Double-Blind, Double-Masked Study of the Efficacy and Safety of BCD-132 (JSC BIOCAD, Russia) Using an Active Reference Drug (Teriflunomide) for the Treatment of Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Biocad 336
Not applicableLooking for participantsNCT05344469
What this trial is testing

A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 800
Testing effectiveness (Phase 2)Study completedNCT00489489
What this trial is testing

Phase II Study of Teriflunomide as Adjunctive Therapy to Interferon-beta in Subjects With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Sanofi 118
Post-approval studies (Phase 4)Study completedNCT01895335
What this trial is testing

Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients

Who this might be right for
Multiple Sclerosis
Sanofi 1,001
Not applicableStudy completedNCT02651545
What this trial is testing

Effects of Teriflunomide (Aubagio) on Cognitive and Vocational Outcomes in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
State University of New York at Buffalo 60
Testing effectiveness (Phase 2)WithdrawnNCT06176235
What this trial is testing

Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital
Large-scale testing (Phase 3)Study completedNCT02792218
What this trial is testing

Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 930
Testing effectiveness (Phase 2)Study completedNCT00228163
What this trial is testing

Long Term Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses

Who this might be right for
Multiple Sclerosis
Sanofi 147
Large-scale testing (Phase 3)Study completedNCT00883337
What this trial is testing

A Study Comparing the Effectiveness and Safety of Teriflunomide and Interferon Beta-1a in Patients With Relapsing Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Sanofi 324
Large-scale testing (Phase 3)Study completedNCT00751881
What this trial is testing

An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Sanofi 1,169
Large-scale testing (Phase 3)Active Not RecruitingNCT06141473
What this trial is testing

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Sanofi 1,655
Post-approval studies (Phase 4)Study completedNCT04129736
What this trial is testing

Teriflunomide Concentration in Serum and Cerebrospinal Fluid From Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Pharmacokinetics
Jan Lycke 12
Large-scale testing (Phase 3)Ended earlyNCT04338061
What this trial is testing

Study of Evobrutinib in Participants With RMS (evolutionRMS 2)

Who this might be right for
Relapsing Multiple Sclerosis
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 1,166
Testing effectiveness (Phase 2)UnknownNCT06176911
What this trial is testing

The Combination of Teriflunomide and Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 124
Testing effectiveness (Phase 2)Study completedNCT04806737
What this trial is testing

Teriflunomide vs. Placebo During Gluten Challenge in Celiac Disease

Who this might be right for
Celiac Disease
Oslo University Hospital 15
Not applicableUnknownNCT05075499
What this trial is testing

Immune Response to COVID-19 Vaccine in Multiple Sclerosis Patients Treated With Teriflunomide and Alemtuzumab

Who this might be right for
Multiple Sclerosis
Sheba Medical Center 70
Post-approval studies (Phase 4)Study completedNCT03856619
What this trial is testing

To Evaluate the Safety and Efficacy of Teriflunomide in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Relapsing Multiple Sclerosis
Sanofi 121
Large-scale testing (Phase 3)Ended earlyNCT04338022
What this trial is testing

Study of Evobrutinib in Participants With RMS (evolutionRMS 1)

Who this might be right for
Relapsing Multiple Sclerosis
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 1,124
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation